SHARE:   Share to Facebook Share to Twitter Share to Linked In Share via Email  

Back To Search Results

S27 - "Best Of" Session: Neuromuscular Disease Therapeutics

Event Time: Wednesday April 26, 2017 8:00 am to 9:00 am
Topic(s): Neuromuscular and Clinical Neurophysiology (EMG)
Director(s):
Description: A platform session that brings together the top four scoring abstracts in a particular topic, as rated by the topic reviewers. Offers an opportunity to interact with the author in a smaller setting at the conclusion of the session.
Completion Message:
CME Credits: 1
Core Competencies:

Program Speakers - Tentative

Start/End Time Title Faculty
8:35 AM - 8:45 AM Panel Discussion None  
8:45 AM - 9:00 AM Meet the Investigators None  

Disclosures

Speaker Disclosure

Abstract Presenters

Start Time Pub. Title Presenter
8:00 AM 001 Rasagiline for the Treatment of ALS: a randomized controlled study Richard Barohn, MD, FAAN
Disclosure:
Dr Barohn received personal compensation for activities with Grifols & Genzyme as a member of the Speakers Bureau and NuFactor as a consultant.

8:08 AM 002 Oral Fingolimod in Chronic Inflammatory Demyelinating Polyradiculoneuropathy (FORCIDP): Results from a Phase III Randomized Placebo-controlled Trial Hans-Peter Hartung, MD, FAAN
Disclosure:
Consulting and/or speaking fees (Bayer, Biogen, CSL Behring, Grifols, Merck Serono, Novartis, Roche, and Sanofi Genzyme).

8:16 AM 003 AVXS-101 Phase 1 Gene Therapy Clinical Trial in SMA Type 1: Interim Data Demonstrates Improvements in Supportive Care Use Jerry Mendell, MD, FAAN
Disclosure:
Dr. Mendell has received personal compensation for activities with AveXis, Inc. and Sarepta Therapeutics as a consultant. Dr. Mendell has received research support from Sarepta Therapeutics Inc. and AveXis, Inc.

8:24 AM 004 Phase 2 Open-Label Extension (OLE) Study of Patisiran, an Investigational RNA interference (RNAi) Therapeutic for the Treatment of Hereditary ATTR Amyloidosis with Polyneuropathy David Adams
Disclosure:
Dr. Adams has received personal compensation for activities with Alnylam Pharmaceuticals.

Register Now

Related Courses

Sunday April 22, 2018

7:00 AM-9:00 AM
C30 Peripheral Neuropathy I: Anatomical Basis and Acquired Demyelinating Neuropathies Michael Shy MD
1:00 PM-3:00 PM
C40 Peripheral Neuropathy II: Diabetic and Inherited Neuropathies Michael Shy MD
1:00 PM-5:30 PM
C47 Neuromuscular Ultrasound Skills Workshop (Registration Required) Craig Zaidman MD
3:30 PM-5:30 PM
C54 Peripheral Neuropathy III: Genetic Testing and Next Generation Sequencing Michael Shy MD

Tuesday April 24, 2018

1:00 PM-5:30 PM
C118 EMG Skills Workshop: Basic Ezgi Tiryaki MD, FAAN

Wednesday April 25, 2018

7:00 AM-9:00 AM
C141 Mastering EMG Waveform Recognition Skills in Just Two Hours! Devon Rubin MD, FAAN
1:00 PM-3:00 PM
C154 Small Fiber Neuropathies: Sensory, Autonomic, and Both I: Focus on Autonomic Nervous System Christopher Gibbons MD, FAAN
3:30 PM-5:30 PM
C168 Small Fiber Neuropathies: Sensory, Autonomic, and Both II: Focus on Sensory Nervous System Christopher Gibbons MD, FAAN

Thursday April 26, 2018

7:00 AM-9:00 AM
C178 Clinical EMG I: Principles and Practice of NCS and Needle EMG Ruple Laughlin MD, FAAN
1:00 PM-3:00 PM
C191 Clinical EMG II: Neuromuscular Junction Testing and Quantitative EMG Mark Bromberg MD, PhD, FAAN
3:30 PM-5:30 PM
C205 Clinical EMG III: Nerve Conduction Criteria and Electrodiagnostic Approaches Mark Bromberg MD, PhD, FAAN
6:30 PM-9:30 PM
C209 Case Studies: Unusual Diagnostic and Management of Cases in Neuromuscular Disease Anne Connolly MD, FAAN

MEMBER LOG IN

Forgot Password?